Tema Oncology ETF (CANC) Institutional Ownership $25.39 -0.25 (-0.98%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tema Oncology ETF (NASDAQ:CANC)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$13.77MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.81M Get CANC Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Oncology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Tema Oncology ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/10/2025 Thrivent Financial for Lutherans517,837$13.16M0.0%+29.6%20.307% 11/15/2024 Jane Street Group LLC44,311$1.26M0.0%-69.1%2.547% 11/7/2024 Thrivent Financial for Lutherans399,509$11.35M0.0%+25.1%22.960% 8/13/2024 Thrivent Financial for Lutherans319,376$8.62M0.0%N/A19.010% (Data available from 1/1/2016 forward) CANC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANC shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Oncology ETF shares: Thrivent Financial for Lutherans ($13.16M), Jane Street Group LLC ($1.26M).Learn more on CANC's institutional investors. Which institutional investors have been buying Tema Oncology ETF stock? The following institutional investors have purchased Tema Oncology ETF stock in the last 24 months: Thrivent Financial for Lutherans ($517.84K). How much institutional buying is happening at Tema Oncology ETF? Institutional investors have bought a total of 517,837 shares in the last 24 months. This purchase volume represents approximately $13.77M in transactions. Which Tema Oncology ETF major shareholders have been selling company stock? The following institutional investors have sold Tema Oncology ETF stock in the last 24 months: Jane Street Group LLC ($98.88K). How much institutional selling is happening at Tema Oncology ETF? Institutional investors have sold a total of 98,880 shares in the last 24 months. This volume of shares sold represents approximately $2.81M in transactions. Related Companies GNOM Major Shareholders MDCP Major Shareholders UFO Major Shareholders HRTS Major Shareholders ZAP Major Shareholders VPN Major Shareholders FDCF Major Shareholders AGNG Major Shareholders TARK Major Shareholders BLCN Major Shareholders This page (NASDAQ:CANC) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.